78 related articles for article (PubMed ID: 15864916)
21. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
22. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
23. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
24. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
[TBL] [Abstract][Full Text] [Related]
25. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
26. Roles of interferon-gamma and interleukin-4 in murine lupus.
Peng SL; Moslehi J; Craft J
J Clin Invest; 1997 Apr; 99(8):1936-46. PubMed ID: 9109438
[TBL] [Abstract][Full Text] [Related]
27. Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice.
Mustafa A; Holladay S; Witonsky S; Zimmerman K; Manari A; Countermarsh S; Karpuzoglu E; Gogal R
Birth Defects Res B Dev Reprod Toxicol; 2011 Feb; 92(1):82-94. PubMed ID: 21312323
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
[TBL] [Abstract][Full Text] [Related]
29. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.
Hong Y; Wang T; Huang C; Cheng W; Lin B
Lupus; 2008 Sep; 17(9):814-21. PubMed ID: 18755863
[TBL] [Abstract][Full Text] [Related]
30. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
[TBL] [Abstract][Full Text] [Related]
31. The role of CD5+ B cells in the production of autoantibodies in murine systemic lupus erythematosus.
Reap EA; Sobel ES; Cohen PL; Eisenberg RA
Ann N Y Acad Sci; 1992 May; 651():588-90. PubMed ID: 1376085
[No Abstract] [Full Text] [Related]
32. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4.
Dang H; Ogawa N; Takei M; Lazaridis K; Talal N
J Immunol; 1993 Dec; 151(12):7260-7. PubMed ID: 8258723
[TBL] [Abstract][Full Text] [Related]
33. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development.
Enghard P; Humrich JY; Chu VT; Grussie E; Hiepe F; Burmester GR; Radbruch A; Berek C; Riemekasten G
Eur J Immunol; 2010 Jun; 40(6):1809-18. PubMed ID: 20333624
[TBL] [Abstract][Full Text] [Related]
34. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
35. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.
Sobel ES; Mohan C; Morel L; Schiffenbauer J; Wakeland EK
J Immunol; 1999 Feb; 162(4):2415-21. PubMed ID: 9973523
[TBL] [Abstract][Full Text] [Related]
36. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic alpha beta T cell. Separation of autoantigen-specific and -nonspecific help.
Peng SL; Fatenejad S; Craft J
J Immunol; 1996 Dec; 157(12):5225-30. PubMed ID: 8955166
[TBL] [Abstract][Full Text] [Related]
37. Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice.
Slack JH; Hang L; Barkley J; Fulton RJ; D'Hoostelaere L; Robinson A; Dixon FJ
J Immunol; 1984 Mar; 132(3):1271-5. PubMed ID: 6537961
[TBL] [Abstract][Full Text] [Related]
38. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
39. B cell subsets in pristane-induced autoimmunity.
Richards HB; Reap EA; Shaw M; Satoh M; Yoshida H; Reeves WH
Curr Top Microbiol Immunol; 2000; 252():201-7. PubMed ID: 11125477
[No Abstract] [Full Text] [Related]
40. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.
Luo J; Niu X; Zhang M; Zhang K; Chen M; Deng S
Autoimmunity; 2015 Mar; 48(2):80-6. PubMed ID: 25347333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
